Crow Point Partners’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
2019
Q3
$104K Hold
2019
Q2
$106K Hold
2019
Q1
$116K Hold
2018
Q4
$90K Hold
2018
Q3
$102K Buy
2018
Q2
$98K Buy
2018
Q1
$20K Buy
2017
Q4
$16K Buy